MINOCYCLINE IN VITRO DECREASES MICROGLIAL ACTIVATION IN A CSTB-DEFICIENT MOUSE, A MODEL FOR PROGRESSIVE MYOCLONUS EPILEPSY, EPM1

被引：0
|
作者：
Okuneva, O. [1 ]
Korber, I [1 ]
Joensuu, T. [2 ,3 ]
Lehesjoki, A. E. [2 ,3 ]
Kopra, O. [2 ,3 ]
机构：
[1] Univ Helsinki, Ctr Neurosci, Folkhalsan Inst Genet, Helsinki, Finland
[2] Univ Helsinki, Folkhalsan Inst Genet, Haartman Inst, Dept Med Genet & Res Programs,Unit Mol Med, Helsinki, Finland
[3] Univ Helsinki, Ctr Neurosci, Helsinki, Finland
来源：
GLIA | 2011年 / 59卷
关键词：
progressive myoclonus epilepsy of Unverricht-Lundborg type; microglia activation; minocycline;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 49 条
  • [1] Abnormal Microglial Activation in the Cstb-/- Mouse, A Model for Progressive Myoclonus Epilepsy, EPM1
    Okuneva, Olesya
    Korber, Inken
    Li, Zhilin
    Tian, Li
    Joensuu, Tarja
    Kopra, Outi
    Lehesjoki, Anna-Elina
    GLIA, 2015, 63 (03) : 400 - 411
  • [2] Early Microglial Activation Precedes Neuronal Loss in the Brain of the Cstb-/- Mouse Model of Progressive Myoclonus Epilepsy, EPM1
    Tegelberg, Saara
    Kopra, Outi
    Joensuu, Tarja
    Cooper, Jonathan D.
    Lehesjoki, Anna-Elina
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (01): : 40 - 53
  • [3] Microglia-mediated synaptic pruning in the Cstb-/- mouse model for progressive myoclonus epilepsy, EPM1
    Tegelberg, S.
    Hakala, P.
    Joensuu, T.
    Lehesjoki, A-E.
    GLIA, 2017, 65 : E313 - E313
  • [4] Microglia mediated synaptic pruning is altered in the Cstb-/- mouse model for progressive myoclonus epilepsy, EPM1
    Tegelberg, S.
    Kuosa, E.
    Kallo, H.
    Hakala, P.
    Joensuu, T.
    Lehesjoki, A. -E.
    GLIA, 2019, 67 : E350 - E351
  • [5] Cellular localization of the cystatin B (CSTB) protein defective in progressive myoclonus epilepsy, EPM1
    Alakurtti, K
    Weber, E
    Bauerfeld, G
    Rinne, R
    Saukko, P
    Joensuu, TH
    Salmikangas, P
    Carpén, O
    Lahtinen, U
    Lehesjoki, AE
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 541A - 541A
  • [6] Proteomics studies of progressive myoclonus epilepsy (EPM1) using cystatin B-deficient mice model
    Reeben, M
    Komarovski, V
    Auriola, S
    Arbatova, J
    EPILEPSIA, 2003, 44 : 56 - 56
  • [7] EARLY ACTIVATION OF MICROGLIA HAS A CENTRAL ROLE IN THE DISEASE PATHOGENESIS OF PROGRESSIVE MYOCLONUS EPILEPSY, EPM1
    Korber, I.
    Joensuu, T.
    Lehesjoki, A. -E.
    Kopra, O.
    GLIA, 2013, 61 : S76 - S76
  • [8] Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)
    Pennacchio, LA
    Lehesjoki, AE
    Stone, NE
    Willour, VL
    Virtaneva, K
    Miao, JM
    DAmato, E
    Ramirez, L
    Faham, M
    Koskiniemi, M
    Warrington, JA
    Norio, R
    delaChapelle, A
    Cox, DR
    Myers, RM
    SCIENCE, 1996, 271 (5256) : 1731 - 1734
  • [9] EARLY ACTIVATION OF MICROGLIA HAS A CENTRAL ROLE IN THE DISEASE PATHOGENESIS OF PROGRESSIVE MYOCLONUS EPILEPSY, EPM1
    Korber, I
    Joensuu, T.
    Lehesjoki, A. E.
    Kopra, O.
    GLIA, 2011, 59 : S76 - S76
  • [10] Early activation of microglia plays a central role in the disease pathogenesis of progressive myoclonus epilepsy, EPM1
    Korber, I.
    Joensuu, T.
    Katayama, S.
    Hakala, P.
    Einarsdottir, E.
    Kere, J.
    Lehesjoki, A. -E.
    GLIA, 2015, 63 : E169 - E169
12345